Companies: 10,795·Total market cap: $144.5T
Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc.

INTSNASDAQHealthcare● Active
$3.78
+$0.01(+0.27%)
Market Cap$7128917
P/E Ratio
52W High$43.5
52W Low$3.65
Overview

Intensity Therapeutics, Inc.(INTS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · INTS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B($0.00B)$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.01B$0.01B$0.00B$0.01B$0.01B
G&A Expenses$0.01B$0.01B$0.00B$0.00B$0.00B
Total Operating Expenses$0.01B$0.02B$0.01B$0.01B$0.01B
Operating Income($0.01B)($0.02B)($0.01B)($0.01B)($0.01B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.01B)($0.02B)($0.01B)($0.01B)($0.01B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.01B)($0.02B)($0.01B)($0.01B)($0.01B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-8.56$-29.25$-34.50$-55.50$-58.00
Wtd Avg Shares0.01B0.00B0.00B0.00B0.00B
EBITDA($0.01B)($0.02B)($0.01B)($0.01B)($0.01B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Intensity Therapeutics, Inc.

关于Intensity Therapeutics, Inc.(INTS)损益表

Intensity Therapeutics, Inc.(INTS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,INTS实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.01B)(净利率—)。

常见问题

INTS · 4 问

Intensity Therapeutics, Inc.(INTS)2025财年营收为$0.00B,同比down—%。

INTS revenueINTS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09